Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

Chromoendoscopy detects more Lynch syndrome lesions than white light endoscopy

22 Nov 2019

In patients with Lynch syndrome, chromoendoscopy (ChE) allows for the detection of more lesions than white light endoscopy (WLE), especially in terms of adenomas, flat lesions and proximal lesions, reports a recent meta-analysis.

Researchers retrieved four studies from Medline, which compared the detection of neoplastic lesions using between least two endoscopic imaging methods. This resulted in a sample of 164 patients undergoing ChE and 190 undergoing WLE. Only prospective studies with parallel or crossover designs, and which included Lynch syndrome patients, were eligible for inclusion.

A total of 311 and 169 lesions were detected by ChE and WLE, respectively. The resulting detection rate of ChE was almost twice that of WLE (rate ratio [RR], 1.97, 95 percent confidence intervals [CI], 1.63–2.38). ChE was also able to detect more adenomas than WLE (81 vs 56), such that its detection rate was at least 1.5 times greater (RR, 1.53, 95 percent CI, 1.07–2.17). More than half of all the adenomas in all studies included was detected by ChE.

Flat lesions were also more detectable using ChE than WLE (173 vs 52; RR, 3.4, 95 percent CI, 2.47–4.67). More than three-fourths (77 percent) of all flat lesions were identified using ChE. A similar effect was reported for proximal lesions, which were detected by ChE at almost three times the rate of WLE (86 vs 30; RR, 2.93, 95 percent CI, 1.91–4.50).

“More studies are needed comparing [high-definition] technology and advanced imaging methods with ChE for adenoma detection … and to assess the impact of ChE on advanced polyps and cancer detection,” said researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.